Orion Minerals (ORN) Investor Update summary

Scientific and operational milestones

• Achieved regulatory clearance from USDA APHIS for GLA-producing safflower, enabling permit-free operations.

• GLA expression in safflower oil reached 60%, surpassing expectations and improving project economics.

• Advanced meat replacement program with successful scale-up and confirmation of animal genes in pea seeds.

• Progressed soybean project to T2 generation with significant animal protein expression.

• Expanded genetically modified safflower seed production by 42 times and GLASO seeds by 25 times year-over-year.

Business development and strategic partnerships

• Acquired a soybean processing facility with 10,000 tonnes/year capacity, enhancing downstream capabilities.

• Signed MOU with BioSeres Crop Solutions to secure up to 20,000 tonnes of HP4 soybeans over three years.

• HP4 soybean platform offers traceability, lower water and carbon footprint, and supports sustainable value chains.

• Integration of molecular farming with HP4 platform aims to drive carbon neutrality and agricultural regeneration.

Market opportunity and business plan execution

• Total addressable market for 2025 estimated at $827 billion, with a serviceable addressable market of $37 billion.

• Business plan includes four stages: traditional soybean processing, sustainable HP4 soy integration, technology-enhanced product development, and full molecular farming ingredient production.

• Network of farmers, sustainable procurement, and global customer base in 14 countries support scalable growth.